isosorbide mononitrate, Imdur, Ismo, Monoket
Title: isosorbide mononitrate, Imdur, Ismo, MonoketCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/10/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 10, 2017 Category: Cardiology Source Type: news

Ismo (Isosorbide Mononitrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 25, 2017 Category: Drugs & Pharmacology Source Type: news

Common medication for heart failure patients does not increase activity level
Heart failure patients with preserved ejection fraction -- where the heart becomes stiff and cannot relax or fill properly -- did not have increased exercise tolerance after taking isosorbide mononitrate, compared to a placebo. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 9, 2015 Category: Science Source Type: news

NEAT-HFpEF: Activity Levels Fall on Nitrates in Preserved-EF HFNEAT-HFpEF: Activity Levels Fall on Nitrates in Preserved-EF HF
There wasn't much neat about treatment with isosorbide mononitrate in the small randomized trial; it didn't improve functional capacity or quality-of-life measures and may even have harmed. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 8, 2015 Category: Cardiology Tags: Cardiology News Source Type: news

Common medication for heart failure patients does not increase activity level
ORLANDO, Fla. — Heart failure patients with preserved ejection fraction (HFpEF) — where the heart becomes stiff and cannot relax or fill properly — did not have increased exercise tolerance after taking isosorbide mononitrate, compared to a placebo, according to a study presented today at the American Heart Association’s Scientific Sessions 2015. The findings come [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - November 8, 2015 Category: Hospital Management Source Type: news

Isosorbide Mononitrate Might Reduce Physical Activity in Heart Failure Patients with Preserved Ejection (FREE)
By Frederick A. Masoudi, MD, MSPH, FACC, FAHA Dr. Masoudi is an associate editor with NEJM Journal Watch Cardiology, from which this story was adapted. See full coverage at the link below.Nitrates may adversely affect activity levels in patients with heart failure and preserved left ventricular ejection fraction, according to a multicenter, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 8, 2015 Category: Primary Care Source Type: news

isosorbide mononitrate, Imdur, Ismo, Monoket
Title: isosorbide mononitrate, Imdur, Ismo, MonoketCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/30/2014 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 30, 2014 Category: Cardiology Source Type: news

Monoket (Isosorbide Mononitrate, USP) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 14, 2014 Category: Drugs & Pharmacology Source Type: news

PSNC: Shortage of isosorbide mononitrate tablets 10mg, 20mg and 40mg
Source: PSNC Area: News The Pharmaceutical Services Negotiating Committee (PSNC) has re-iterated advice from the Chief Pharmaceutical Officer on the shortage of isosorbide mononitrate tablets (10mg, 20mg and 40mg).   The PSNC has confirmed the following with the Department of Health: "Contractors will be reimbursed for dispensing an unlicensed medicine against prescriptions for all strengths of isosorbide mononitrate (10mg, 20mg and 40mg) tablets.  However, contractors will need to ensure that these prescriptions have been clearly prescribed as "unlicensed" and then endorsed with the actual pr...
Source: NeLM - Cardiovascular Medicine - March 1, 2013 Category: Cardiology Source Type: news

Shortage of isosorbide mononitrate 10mg, 20mg and 40mg tablets
Source: Department of Health (DH) Area: News The Department of Health has issued a letter highlighting a current shortage of all normal release isosorbide mononitrate presentations (10, 20 and 40mg tablets) because of problems with the availability of raw materials.   The shortage of this medicine may last for several months and current information indicates that normal supply is unlikely to resume before the end of April 2013. However, the situation may change from week to week, as it is understood that some companies may obtain some stock before that time, while others are importing unlicensed isosorbide mononi...
Source: NeLM - News - February 14, 2013 Category: Drugs & Pharmacology Source Type: news